TickerFacts.

BetterLife Pharma Inc. (BETRF): R&D Expense

Annual figures by period end, from SEC filings.

Not updated since 2019-01-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

430.5K CAD
Year ended 2019-01-31
2018-01-31: 90.8K CAD2019-01-31: 430.5K CAD430.5K CAD
2018-01-31 R&D Expense (CAD) 2019-01-31
Period endedR&D ExpenseChange YoYSource filing
2019-01-31430.5K CAD+373.9%2019-05-03, From 2018-02-01
2018-01-3190.8K CADn/a2019-05-03, From 2017-02-01